Important Notice: All grants and sponsorships must be submitted in NGCS by October 1, 2026, before the system closes to new submissions. Submissions received by this date will receive a full review in NGCS. The new platform is scheduled to launch on November 16, 2026.
Novartis is committed to meeting the needs of patients by supporting non-profit patient advocacy organizations in educating and helping patients, caregivers, and the public in therapeutic areas where our company has an interest.
We will evaluate patient education grant requests that are independent of commercial bias and are non-promotional in nature. Patient education grants can be requested to support a variety of different activities including disease awareness, live events, web-based education, print/media, newsletters, websites, seminars, etc. We will only accept grant requests for patient education programs from 501(c)3, 501(c)4, or 501(c)6 nonprofit organizations.